コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 st-TCR recovery of transcription and for the Cockayne syndrome.
2 position, or in rare cases, XP combined with Cockayne syndrome.
3 lso explain the diverse clinical features of Cockayne syndrome.
4 NER machinery and they have implications for Cockayne syndrome.
5 ementation group D, trichothiodystrophy, and Cockayne syndrome.
6 n the human RAD2 counterpart, XPG, result in Cockayne syndrome.
7 d in the severe human neurocutaneous disease Cockayne syndrome.
8 -sensitive syndrome and the severe progeroid Cockayne syndrome.
9 kidney failure, features that resemble human Cockayne syndrome.
10 family suspected on clinical grounds to have Cockayne syndrome.
11 CDK5RAP2 and progeria-associated defects of Cockayne syndrome.
12 ciated with the severe neurological disorder Cockayne syndrome.
13 insight into the clinical manifestations of Cockayne syndrome.
14 utations in the CSB gene are associated with Cockayne syndrome.
15 led DNA repair, and mutations in CSB lead to Cockayne syndrome.
16 s in this association underlie some forms of Cockayne syndrome.
17 somal recessive segmental progeroid disorder Cockayne syndrome.
18 an transcription-repair coupling factor CSB (Cockayne syndrome 8) are highly homologous to known heli
20 the Saccharomyces cerevisiae homolog of the Cockayne syndrome A (CSA) gene, which we designate as RA
22 repair (TCR), in which three gene products, Cockayne syndrome A (CSA), Cockayne syndrome B (CSB), an
24 e CSA or CSB complementation genes cause the Cockayne syndrome, a severe genetic disorder that result
26 ER-associated DNA repair disorders including Cockayne syndrome and some forms of xeroderma pigmentosu
27 for impaired ribosomal DNA transcription in Cockayne syndrome and suggests that transcription-couple
29 lobal genome repair, which are implicated in Cockayne syndrome and xeroderma pigmentosum group C, res
30 Notably, this blockage is exacerbated in Cockayne Syndrome and xeroderma pigmentosum patient-deri
32 ncluding other xeroderma pigmentosum groups, Cockayne syndrome, and a newly established ultraviolet-s
33 y virus-1 infection, acute myeloid leukemia, Cockayne syndrome, and the familial cancer predispositio
34 the genetic diseases xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy, highlighting
35 might contribute to the cachexia observed in Cockayne syndrome as well as chemotherapy-induced anorec
40 ee gene products, Cockayne syndrome A (CSA), Cockayne syndrome B (CSB), and ultraviolet stimulated sc
42 the first example of an endogenous protein, Cockayne Syndrome B (CSB), that can bind selectively wit
44 Elongin ubiquitin ligase assembles with the Cockayne syndrome B helicase (CSB) in response to DNA da
52 ludes the porphyrias, xeroderma pigmentosum, Cockayne syndrome, Bloom syndrome, and Rothmund-Thomson
53 se the neurodevelopmental progeroid disorder Cockayne syndrome, but little is known about how XPG los
55 more, transcription coupled repair-deficient Cockayne syndrome cells are not hypersensitive to UVA/6-
56 We suggest that other genes are mutated in Cockayne syndrome cells that contribute to the deficienc
58 even-nineteen lysine-rich in leukemia (ELL), Cockayne syndrome complementation group B (CSB), and elo
61 ties suggestive of the xeroderma pigmentosum/Cockayne syndrome complex including sun sensitivity, neu
62 hty-three patients had XP, 3 patients had XP/Cockayne syndrome complex, and 1 patient had XP/trichoth
65 eroid disorders (xeroderma pigmentosum (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD)), w
69 ion of the 8-oxoguanine in DNA by normal and Cockayne Syndrome (CS) cell extracts has been investigat
73 -lines RT4 and RT112, normal fibroblasts and Cockayne Syndrome (CS) fibroblasts following gamma-radia
105 in adducts, DPC sequencing, we discover that Cockayne syndrome (CS) proteins CSB and CSA provide resi
106 repair, leading to sequential engagement of Cockayne syndrome (CS) proteins CSB and CSA, and to prot
107 Mutations of CSB account for the majority of Cockayne syndrome (CS), a devastating hereditary disorde
108 esult in combined xeroderma pigmentosum (XP)/Cockayne syndrome (CS), a severe DNA repair disorder cha
109 efective transcription-coupled repair (TCR), Cockayne syndrome (CS), and early death, but the molecul
110 roderma pigmentosum (XP), or aging disorders Cockayne syndrome (CS), and trichothiodystrophy (TTD).
112 Defective TCR in humans is associated with Cockayne syndrome (CS), typically caused by defects in e
118 broblasts from individuals with two forms of Cockayne syndrome (CS-A and CS-B), a rare disorder in wh
119 ficient in XPC or in the genes implicated in Cockayne syndrome (CSA and CSB) indicated that the drug
122 ere form a functional description of a plant Cockayne syndrome factor A (CSA) ortholog, and demonstra
123 igmentosum group A (XP-A), XP-D, XP-F, XP-G, Cockayne syndrome group A (CS-A), and CS-B] are hypersen
124 ls in transcription-coupled repair-deficient Cockayne syndrome group A (Csa(-/-)) and group B (Csb(-/
126 scription-coupled repair is dependent on the Cockayne syndrome group A and B proteins, as well as TFI
127 ermore, VCP/p97 and UBXD7 associate with the Cockayne syndrome group A-DDB1-Cul4A complex, an E3 liga
129 d nucleotide excision repair factor (TC-NER) Cockayne syndrome group B (CSB) and the global genome NE
131 lack the RAD26 gene, a homolog of the human Cockayne syndrome group B (CSB) gene, and, importantly,
133 utations of OGG1 acetylation sites increased Cockayne syndrome group B (CSB) protein expression.
134 t to identify protein partners and roles for Cockayne syndrome group B (CSB) protein in this organell
135 diated by specific factors such as the human Cockayne syndrome group B (CSB) protein or its yeast hom
138 e majority of CS patients carry mutations in Cockayne syndrome group B (CSB), best known for its role
139 d nucleotide excision repair (TC-NER) factor Cockayne syndrome group B (CSB), but not the global geno
142 emoval of chromosomal DPCs requires both the Cockayne syndrome group B gene as well as "downstream" T
144 AD26 encodes a protein that is homologous to Cockayne syndrome group B protein (CSB) and is a member
145 DNA damage but cannot begin repair until the Cockayne syndrome group B protein (CSB) binds ubiquitin.
150 of NEIL2 with RNA polymerase II, along with Cockayne syndrome group B protein, TFIIH, and other BER
151 he transcription-blocking lesion, perhaps by Cockayne syndrome group B translocase, or during the syn
158 e implicated in the human hereditary disease Cockayne syndrome, may have a role in transcription.
163 roderma pigmentosum, trichothiodystrophy and Cockayne syndrome onto defined communities reveals clust
164 different syndromes, xeroderma pigmentosum, Cockayne syndrome, or trichothiodystrophy, depending on
169 ns and suggest that the manifestation of the Cockayne Syndrome phenotype in humans results from the p
173 ve transcription and requires both wild-type Cockayne syndrome protein B (CSB) function and the prese
174 g on the roles of stalled RNA polymerase II, Cockayne syndrome protein B (CSB), CSA and UV-stimulated
179 hanisms underlying xeroderma pigmentosum and Cockayne syndrome, the two main diseases linked to mutat
180 ome (HGPS), Werner syndrome, Bloom syndrome, Cockayne syndrome, trichothiodystrophy, ataxia-telangiec
181 appears common to ataxia-telangiectasia and Cockayne syndrome, two other DNA repair disorders with n
183 CSA-1, which is an ortholog of the mammalian Cockayne Syndrome type-A protein involved in transcripti
185 genetically linked to xeroderma pigmentosum/Cockayne syndrome, Warsaw breakage syndrome, and dyskera
186 roject, which revealed that Drosophila lacks Cockayne syndrome WD repeat protein (CSA), CSB, or UV-st
187 This response is absent in the human disease Cockayne syndrome, which is caused by loss of the Cockay
188 he autosomal-recessive neurological disorder Cockayne syndrome, which is characterized by progeriod f
189 diseases with progressive neurodegeneration (Cockayne syndrome, Xeroderma pigmentosum, and Ataxia tel